eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | hodgkin lymphoma |
| Comorbidity | C0079744|diffuse large b-cell lymphoma |
| Sentences | 7 |
| PubMedID- 24024472 | Anti-tumor activity was assessed in two xenograft scid (severe combined immune deficiency) mouse models of non-hodgkin lymphoma with the su-dhl-4 (diffuse large b-cell lymphoma) and jeko-1 (mantle cell lymphoma) cell lines. |
| PubMedID- 24665028 | B-cell non-hodgkin's lymphomas were predominant, with diffuse large b-cell lymphoma being the most common subtype in the entire group. |
| PubMedID- 24694573 | All cases were non-hodgkin's lymphoma, with diffuse large b-cell lymphoma in majority. |
| PubMedID- 25215588 | diffuse large b-cell lymphoma (dlbcl) is one of the most common non-hodgkin lymphomas in adults. |
| PubMedID- 22518331 | diffuse large b-cell lymphoma represents approximately 30%-40% of all diagnoses of non-hodgkin's lymphoma and may represent up to 80% of all lymphomas that arise in the palatine tonsils. |
| PubMedID- 25774481 | Burkitt lymphoma and diffuse large b-cell lymphoma represent the majority of mature b-cell non-hodgkin lymphomas in children, adolescents, and young adults. |
| PubMedID- 23323070 | At hospital das clinicas da faculdade de medicina da universidade de sao paulo - hcfmusp, diffuse large b-cell lymphoma represents 49.7% of all non-hodgkin lymphoma cases. |
Page: 1